Grants and Contributions:
Title:
Improvements in workflow and turnaround time of OneTest PathoGenome
Agreement Number:
917539
Agreement Value:
$499,166.00
Agreement Date:
Oct 29, 2018 - Sep 30, 2020
Description:
Fusion’s current assay has a 24-hour turnaround time and a complex workflow that requires high technical knowledge. The company has identified several avenues to simplify the workflow and bring the turnaround time down to 12 hours. The project will support R&D to investigate these avenues and implement a simplified workflow.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5A 4W9
Reference Number:
172-2018-2019-Q4-917539
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
828602243
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 194 days.
Amendment Date
Dec 13, 2019
Recipient's Legal Name:
Fusion Genomics Corp.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: